Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 9OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Neoplasms 12Carcinoma, Hepatocellular 12Uterine Cervical Neoplasms 10Esophageal Neoplasms 10Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 6Melanoma 5Lung Neoplasms 5Colorectal Neoplasms 5Thyroid Cancer, Papillary 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Motor Activity 4Hematologic Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pain 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Esophageal Squamous Cell Carcinoma 3Uveal Melanoma 2Thyroid Neoplasms 2Skin Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × HER2-positive Breast Cancer × Clear all
NCT07198672 2025-09-30

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

Henan Cancer Hospital

Phase NA Not yet recruiting
45 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡